Recent advances in the development of an inhaled insulin product

André X.C.N. Valente, Robert Langer, Howard A. Stone, David A. Edwards

Research output: Contribution to journalReview articlepeer-review

29 Scopus citations

Abstract

Inhaled insulin first entered clinical human testing in the mid 1990s. Since then, the commercial potential and technical Challenges of an inhaled insulin product have grown increasingly clear, with several pharmaceutical partnerships now targeting treatment of diabetes mellitus through inhalation products in clinical development. While clinical results to date show the therapy to be generally promising, recent data have raised questions related to human safety and slowed progress toward a commercial product. Answering these questions positively in the coming years will be critical to making inhalation therapy a practical diabetes-care reality.

Original languageEnglish (US)
Pages (from-to)9-17
Number of pages9
JournalBioDrugs
Volume17
Issue number1
DOIs
StatePublished - Feb 24 2003

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Recent advances in the development of an inhaled insulin product'. Together they form a unique fingerprint.

Cite this